Overall Score

Growth

Revenue growth remains unproven in the supplied metrics, with revenue per share still reported at 0.

No evidence of durable top-line expansion or improving scale was provided this month.

Profitability

Margins remain at 0 across gross, operating, EBITDA, pretax, and net profit in the fresh ratios.

Returns are still negative, with ROA at -3.9%, ROE at -6.4%, and ROIC at -1.1%.

Financial Health

Liquidity remains strong, with a current ratio of 6.7x and quick ratio of 6.7x.

Leverage is moderate, with debt-to-equity at 0.46x and debt-to-assets at 0.31x, while cash per share is $1.35.

Valuation

The stock still screens as inexpensive on cash-flow-based measures, with EV/FCF at -31.9x and price-to-free-cash-flow at -29.3x due to negative FCF.

Price-to-book remains 4.0x, which is not especially cheap for a business with negative profitability.

Momentum

No recent news was provided to indicate a change in operating or market momentum.

The latest data still shows weak earnings power and negative cash generation, limiting momentum confidence.